Kim et al. claimed that ZER inhibits epidermal growth factor (EGF)-induced CD44 through suppression of the signal transducer and activator of transcription 3 (STAT-3) signalling pathway in SKBR3 human breast cancer cells [17]. This evidence concerns the gene EGF and breast cancer.